Biotechnology company PostEra closed a $24M investment series with participation of I2BF Global Ventures
The information is available only to PREQVECA PRO subscribers. To subscribe go to the Subscription section
The information is available only to PREQVECA PRO subscribers. To subscribe go to the Subscription section